Similarly, a study of methionine–choline-deficient (MCD)-diet induced mouse non-alcoholic steatohepatitis (NASH) found that administering DIM reduced disease and shifted the immune dominance from Th17 cells toward Tregs using AHR-dependent mechanisms (153). Here, AHR is linked to metabolic dysfunction-associated steatohepatitis.